Jacob Krive, PhD, MS

I apply artificial intelligence (AI), machine learning (ML), and clinical analytics to improve patient care and identify new cancer research opportunities through the power of data. Current projects are centered around AI models to identify cardiotoxic oncology treatments, refer patients to cardio-oncology specialists, and maintain a risk score to track every patient for the entire continuum of care. The aims are to support medical practice and discover new scientific cardiotoxicity insights.